Literature DB >> 17347409

Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones.

Janis L Abkowitz1, Jing Chen.   

Abstract

Three properties define hematopoietic stem cells (HSCs): their capacity for quiescence and long survival, their ability to self-renew, and their ability to give rise to a multilineage clone of differentiating and maturing blood cells. Although it is likely that different signals regulate these events, this has been difficult to dissect on a molecular level, since HSC division, their fate decisions, and the earliest differentiation events cannot be directly visualized. Our studies of c-Mpl, the cellular receptor for the cytokine thrombopoietin, suggest that c-Mpl does not control HSC numbers, as had been previously argued, but rather facilitates the early expansion of differentiating clones. These experiments provide a strategy to distinguish the actions of HSCs from earliest progenitor cells in vivo and demonstrate that a selective growth advantage at a level distal to HSC can result in a profound effect on multilineage hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347409      PMCID: PMC1890826          DOI: 10.1182/blood-2006-08-044503

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Little evidence for developmental plasticity of adult hematopoietic stem cells.

Authors:  Amy J Wagers; Richard I Sherwood; Julie L Christensen; Irving L Weissman
Journal:  Science       Date:  2002-09-05       Impact factor: 47.728

2.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

Review 3.  On the molecular origins of the chronic myeloproliferative disorders: it all makes sense.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

Review 4.  Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations.

Authors:  D E Harrison; C T Jordan; R K Zhong; C M Astle
Journal:  Exp Hematol       Date:  1993-02       Impact factor: 3.084

5.  c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.

Authors:  M Ballmaier; M Germeshausen; H Schulze; K Cherkaoui; S Lang; A Gaudig; S Krukemeier; M Eilers; G Strauss; K Welte
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

6.  Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.

Authors:  M Ballmaier; M Germeshausen; S Krukemeier; K Welte
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

7.  Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell.

Authors:  Kenneth Kaushansky
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

8.  Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure.

Authors:  Janis L Abkowitz; Abigail E Robinson; Sujata Kale; Michael W Long; Jing Chen
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

9.  Behavior of hematopoietic stem cells in a large animal.

Authors:  J L Abkowitz; M T Persik; G H Shelton; R L Ott; J V Kiklevich; S N Catlin; P Guttorp
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors.

Authors:  Jennifer Antonchuk; Craig D Hyland; Douglas J Hilton; Warren S Alexander
Journal:  Blood       Date:  2004-05-11       Impact factor: 22.113

View more
  13 in total

Review 1.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

2.  Orientation-specific signalling by thrombopoietin receptor dimers.

Authors:  Judith Staerk; Jean-Philippe Defour; Christian Pecquet; Emilie Leroy; Hélène Antoine-Poirel; Ian Brett; Miki Itaya; Steven O Smith; William Vainchenker; Stefan N Constantinescu
Journal:  EMBO J       Date:  2011-09-02       Impact factor: 11.598

Review 3.  Cell cycle regulation of hematopoietic stem or progenitor cells.

Authors:  Sha Hao; Chen Chen; Tao Cheng
Journal:  Int J Hematol       Date:  2016-03-23       Impact factor: 2.490

Review 4.  Cancer stem cell marker glycosylation: Nature, function and significance.

Authors:  Brody W Mallard; Joe Tiralongo
Journal:  Glycoconj J       Date:  2017-06-17       Impact factor: 2.916

5.  Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells.

Authors:  Katherine Y King; Katie A Matatall; Ching-Chieh Shen; Margaret A Goodell; Sabina I Swierczek; Josef T Prchal
Journal:  Exp Hematol       Date:  2015-06-11       Impact factor: 3.084

Review 6.  Thrombopoietin and hematopoietic stem cells.

Authors:  Carolyn A de Graaf; Donald Metcalf
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

7.  Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.

Authors:  Daniel C Wicke; Johann Meyer; Guntram Buesche; Dirk Heckl; Hans Kreipe; Zhixiong Li; Karl H Welte; Matthias Ballmaier; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

8.  Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.

Authors:  Wei Tong; Yessenia M Ibarra; Harvey F Lodish
Journal:  Exp Hematol       Date:  2007-07-16       Impact factor: 3.084

9.  Stepwise development of hematopoietic stem cells from embryonic stem cells.

Authors:  Kenji Matsumoto; Takayuki Isagawa; Toshinobu Nishimura; Takunori Ogaeri; Koji Eto; Satsuki Miyazaki; Jun-ichi Miyazaki; Hiroyuki Aburatani; Hiromitsu Nakauchi; Hideo Ema
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

Review 10.  Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Authors:  Ayalew Tefferi
Journal:  J Cell Mol Med       Date:  2008-10-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.